Oramed Pharmaceuticals EPS - Earnings per Share 2011-2025 | ORMP
Oramed Pharmaceuticals eps - earnings per share from 2011 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Oramed Pharmaceuticals Annual EPS | |
|---|---|
| 2024 | $-0.48 |
| 2023 | $0.14 |
| 2022 | $-0.94 |
| 2021 | $-0.31 |
| 2021 | $-0.78 |
| 2020 | $-0.56 |
| 2019 | $-0.82 |
| 2018 | $-0.86 |
| 2017 | $-0.79 |
| 2016 | $-0.87 |
| 2015 | $-0.67 |
| 2014 | $-0.62 |
| 2013 | $-0.59 |
| 2012 | $0.00 |
| 2012 | $-0.57 |
| 2011 | $0.00 |
| 2011 | $-0.02 |
| 2010 | $0.00 |
| Oramed Pharmaceuticals Quarterly EPS | |
|---|---|
| 2025-06-30 | $0.31 |
| 2025-03-31 | $-0.19 |
| 2024-12-31 | $-0.26 |
| 2024-09-30 | $-0.48 |
| 2024-06-30 | $0.22 |
| 2024-03-31 | $0.04 |
| 2023-12-31 | $0.33 |
| 2023-09-30 | $-0.08 |
| 2023-06-30 | $-0.03 |
| 2023-03-31 | $-0.08 |
| 2022-12-31 | $-0.22 |
| 2022-09-30 | $-0.18 |
| 2022-06-30 | $-0.27 |
| 2022-03-31 | $-0.27 |
| 2021-12-31 | $0.24 |
| 2021-11-30 | $-0.22 |
| 2021-09-30 | $-0.21 |
| 2021-08-31 | $0.00 |
| 2021-06-30 | $-0.12 |
| 2021-05-31 | $-0.17 |
| 2021-03-31 | $-0.20 |
| 2021-02-28 | $-0.17 |
| 2020-11-30 | $-0.23 |
| 2020-08-31 | $0.00 |
| 2020-05-31 | $-0.10 |
| 2020-02-29 | $-0.21 |
| 2019-11-30 | $-0.15 |
| 2019-08-31 | $0.00 |
| 2019-05-31 | $-0.23 |
| 2019-02-28 | $-0.21 |
| 2018-11-30 | $-0.25 |
| 2018-08-31 | $0.00 |
| 2018-05-31 | $-0.30 |
| 2018-02-28 | $-0.20 |
| 2017-11-30 | $-0.18 |
| 2017-08-31 | $0.00 |
| 2017-05-31 | $-0.15 |
| 2017-02-28 | $-0.24 |
| 2016-11-30 | $-0.20 |
| 2016-08-31 | $0.00 |
| 2016-05-31 | $-0.15 |
| 2016-02-29 | $-0.14 |
| 2015-11-30 | $-0.21 |
| 2015-08-31 | $0.00 |
| 2015-05-31 | $-0.15 |
| 2015-02-28 | $-0.15 |
| 2014-11-30 | $-0.19 |
| 2014-08-31 | $0.00 |
| 2014-05-31 | $-0.18 |
| 2014-02-28 | $-0.12 |
| 2013-11-30 | $-0.14 |
| 2013-08-31 | $0.00 |
| 2013-05-31 | $-0.17 |
| 2013-02-28 | $-0.17 |
| 2012-12-31 | $0.00 |
| 2012-11-30 | $-0.14 |
| 2012-08-31 | $0.00 |
| 2012-05-31 | $-0.09 |
| 2012-02-29 | $-0.17 |
| 2011-11-30 | $-0.01 |
| 2011-09-30 | $0.00 |
| 2011-08-31 | $0.00 |
| 2011-06-30 | $0.00 |
| 2011-05-31 | $0.01 |
| 2011-03-31 | $0.00 |
| 2011-02-28 | $-0.01 |
| 2010-12-31 | $0.00 |
| 2010-11-30 | $-0.01 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.101B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.002B | 25.82 |
| EssilorLuxottica (ESLOY) | France | $171.957B | 0.00 |
| Boston Scientific (BSX) | United States | $154.367B | 35.30 |
| Stryker (SYK) | United States | $140.480B | 27.89 |
| Medtronic (MDT) | Ireland | $122.894B | 17.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.851B | 0.00 |
| Agilent Technologies (A) | United States | $42.956B | 27.80 |
| ResMed (RMD) | United States | $36.903B | 25.54 |
| GE HealthCare Technologies (GEHC) | United States | $34.155B | 16.34 |
| Koninklijke Philips (PHG) | Netherlands | $28.291B | 18.48 |
| Insulet (PODD) | United States | $23.696B | 73.55 |
| Terumo (TRUMY) | Japan | $22.712B | 25.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.842B | 11.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.285B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.828B | 31.74 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.614B | 11.01 |
| ICU Medical (ICUI) | United States | $3.435B | 21.81 |
| Haemonetics (HAE) | United States | $3.423B | 15.23 |
| Envista Holdings (NVST) | United States | $3.308B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.910B | 13.27 |
| LeMaitre Vascular (LMAT) | United States | $2.041B | 41.08 |
| Perrigo (PRGO) | Ireland | $1.949B | 4.88 |
| Curaleaf Holdings (CURLF) | Canada | $1.869B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.644B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.535B | 9.86 |
| Green Thumb Industries (GTBIF) | United States | $1.452B | 63.64 |
| Neogen (NEOG) | United States | $1.406B | 26.96 |
| Tilray Brands (TLRY) | Canada | $1.381B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.261B | 18.27 |
| BioLife Solutions (BLFS) | United States | $1.248B | 370.29 |
| InMode (INMD) | Israel | $0.923B | 10.44 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.790B | 0.00 |
| Surmodics (SRDX) | United States | $0.591B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.513B | 17.64 |
| CeriBell (CBLL) | United States | $0.477B | 0.00 |
| Evolus (EOLS) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.470B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.413B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.300B | 52.60 |
| Sanuwave Health (SNWV) | United States | $0.286B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.285B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.268B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 151.00 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.85 |
| Quanterix (QTRX) | United States | $0.244B | 0.00 |
| Owens & Minor (OMI) | United States | $0.227B | 2.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.220B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.88 |
| FitLife Brands (FTLF) | United States | $0.178B | 21.93 |
| OraSure Technologies (OSUR) | United States | $0.177B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Biote (BTMD) | United States | $0.131B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Sharps Technology (STSS) | United States | $0.104B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.38 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.26 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Zynex (ZYXI) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Bonk (BNKK) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.28 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |